Los Angeles Capital Management LLC Biomarin Pharmaceutical Inc Transaction History
Los Angeles Capital Management LLC
- $26.1 Billion
- Q2 2025
A detailed history of Los Angeles Capital Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 278,189 shares of BMRN stock, worth $15.5 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
278,189
Previous 141,054
97.22%
Holding current value
$15.5 Million
Previous $9.97 Million
53.36%
% of portfolio
0.06%
Previous 0.04%
Shares
21 transactions
Others Institutions Holding BMRN
# of Institutions
675Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.26 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.06 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$876 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$840 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$683 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...